Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
A Study of Zimberelimab(GLS-010) Combined With AVD for Newly Diagnosed Early-stage Hodgkin's Lymphoma
ClinicalTrials.gov study NCT05900765. IPD Sharing: NO. Countries: 1. Publications: 0.
Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00003575. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Trial in Chinese Patients of B-cell Non-Hodgkin's Lymphoma(GB226)
ClinicalTrials.gov study NCT03639181. IPD Sharing: NO. Countries: 1. Publications: 0.
Lenalidomide and Rituximab in Treating Patients With Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00848328. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
ClinicalTrials.gov study NCT03666000. IPD Sharing: NO. Countries: 2. Publications: 0.
A Study of JNJ-75348780 in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT04540796. IPD Sharing: YES. Countries: 8. Publications: 0.
Brentuximab Vedotin in Pre-transplant Induction and Consolidation for Relapsed or Refractory Hodgkin Lymphoma
ClinicalTrials.gov study NCT02243436. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of JNJ-80948543 in Combination With Other CD3 T-Cell Engagers in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R B-Cell NHL)
ClinicalTrials.gov study NCT06660563. IPD Sharing: YES. Countries: 4. Publications: 0.
Evaluate Safety of Axicabtagene Ciloleucel Reinfusion (Axi-Cel-2) in Patients With Relapsed and/or Refractory Second Line High-Risk Non-Hodgkin Lymphoma After Standard of Care Axi-Cel
ClinicalTrials.gov study NCT05794958. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety of SGI-1776, A PIM Kinase Inhibitor in Refractory Prostate Cancer and Relapsed/Refractory Non Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00848601. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Molecular Risk Assessment in Planning Treatment for Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00055640. IPD Sharing: Not stated. Countries: 1. Publications: 0.
European Project for ctDNA Detection as a Biomarker for Non-invasive Therapy Monitoring in Paediatric Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT07356882. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Ofatumumab and ESHAP for the Treatment of Hodgkin's Lymphoma
ClinicalTrials.gov study NCT01195766. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Interferon Alfa Plus Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00015912. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Secondary Prophylaxis in Non-Hodgkin Lymphoma (NHL) and Chemotherapy-induced Thrombocytopenia
ClinicalTrials.gov study NCT01516619. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17
ClinicalTrials.gov study NCT03755804. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma Patients Receiving Antibody Treatment
ClinicalTrials.gov study NCT00398372. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Escalating Doses of DCDS0780A in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT02453087. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cisplatin With Gemcitabine With Dexamethasone in Patients With Aggressive Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00491127. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rituximab Followed by Combination Chemotherapy in Treating Patients With Refractory or Recurrent Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00006669. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.